Literature DB >> 23085928

Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidney.

Timothy M Baran1, Jeremy D Wilson, Soumya Mitra, Jorge L Yao, Edward M Messing, David L Waldman, Thomas H Foster.   

Abstract

We measured the optical properties of freshly excised kidneys with renal parenchymal tumors to assess the feasibility of photodynamic therapy (PDT) in these patients. Kidneys were collected from 16 patients during surgical nephrectomies. Spatially resolved, white light, steady-state diffuse reflectance measurements were performed on normal and neoplastic tissue identified by a pathologist. Reflectance data were fit using a radiative transport model to obtain absorption (μa) and transport scattering coefficients (μs'), which define a characteristic light propagation distance, δ. Monte Carlo (MC) simulations of light propagation from cylindrical diffusing fibers were run using the optical properties extracted from each of the kidneys. Interpretable spectra were obtained from 14 kidneys. Optical properties of human renal cancers exhibit significant inter-lesion heterogeneity. For all diagnoses, however, there is a trend toward increased light penetration at longer wavelengths. For renal cell carcinomas (RCC), mean values of δ increase from 1.28 to 2.78 mm as the PDT treatment wavelength is increased from 630 to 780 nm. MC simulations of light propagation from interstitial optical fibers show that fluence distribution in tumors is significantly improved at 780 versus 630 nm. Our results support the feasibility of PDT in selected renal cancer patients, especially with photosensitizers activated at longer wavelengths.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085928      PMCID: PMC3442176          DOI: 10.1117/1.JBO.17.9.098002

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  32 in total

Review 1.  Percutaneous image-guided radiofrequency ablation of renal malignancies.

Authors:  Ronald J Zagoria
Journal:  Radiol Clin North Am       Date:  2003-09       Impact factor: 2.303

Review 2.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

3.  Design and testing of a white-light, steady-state diffuse reflectance spectrometer for determination of optical properties of highly scattering systems.

Authors:  M G Nichols; E L Hull; T H Foster
Journal:  Appl Opt       Date:  1997-01-01       Impact factor: 1.980

4.  Laparoscopic versus open radical nephrectomy: a 9-year experience.

Authors:  M D Dunn; A J Portis; A L Shalhav; A M Elbahnasy; C Heidorn; E M McDougall; R V Clayman
Journal:  J Urol       Date:  2000-10       Impact factor: 7.450

5.  Methylene blue and the photodynamic therapy of superficial bladder cancer.

Authors:  J L Williams; J Stamp; R Devonshire; G J Fowler
Journal:  J Photochem Photobiol B       Date:  1989-11       Impact factor: 6.252

Review 6.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

7.  Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.

Authors:  Hector R Nava; Shyam S Allamaneni; Thomas J Dougherty; Michele T Cooper; Wei Tan; Gregory Wilding; Barbara W Henderson
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

Review 8.  Laparoscopic renal cryotherapy: biology, techniques and outcomes.

Authors:  T Powell; C Whelan; B F Schwartz
Journal:  Minerva Urol Nefrol       Date:  2005-06       Impact factor: 3.720

9.  Photodynamic therapy for the treatment of non-small cell lung cancer.

Authors:  Charles B Simone; Joseph S Friedberg; Eli Glatstein; James P Stevenson; Daniel H Sterman; Stephen M Hahn; Keith A Cengel
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

10.  Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report.

Authors:  Ulas Sunar; Daniel Rohrbach; Nestor Rigual; Erin Tracy; Ken Keymel; Michele T Cooper; Heinz Baumann; Barbara H Henderson
Journal:  Opt Express       Date:  2010-07-05       Impact factor: 3.894

View more
  3 in total

1.  Determination of optical properties by interstitial white light spectroscopy using a custom fiber optic probe.

Authors:  Timothy M Baran; Michael C Fenn; Thomas H Foster
Journal:  J Biomed Opt       Date:  2013-10       Impact factor: 3.170

2.  Pre-clinical longitudinal monitoring of hemodynamic response to anti-vascular chemotherapy by hybrid diffuse optics.

Authors:  Parisa Farzam; Johannes Johansson; Miguel Mireles; Gabriela Jiménez-Valerio; Mar Martínez-Lozano; Regine Choe; Oriol Casanovas; Turgut Durduran
Journal:  Biomed Opt Express       Date:  2017-04-19       Impact factor: 3.732

3.  Scanning, non-contact, hybrid broadband diffuse optical spectroscopy and diffuse correlation spectroscopy system.

Authors:  Johannes D Johansson; Miguel Mireles; Jordi Morales-Dalmau; Parisa Farzam; Mar Martínez-Lozano; Oriol Casanovas; Turgut Durduran
Journal:  Biomed Opt Express       Date:  2016-01-15       Impact factor: 3.732

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.